Marked against last year's 10-K:
cut words struck through, new words highlighted and underlined.
MD&A 220 words changed in this paragraph; it is 46% similar to last year's version.
Years ended August 31, (in thousands, except per share data) 2026 2025 2024 % Change Operating income $ 699,957 $ 748,303 $ 701,299 6.7% (6.5)% Intangible asset amortization 76,205 73,036 67,383 Restructuring/severance 46,200 259 CEO onboarding costs(1) 19,521 1,675 Business divestiture, disposition, acquisitions and related costs 8,255 17,761 884 India Labor Codes Reform 2,883 — Asset impairment 887 — Client bankruptcy charges 750 — Litigation reserve 650 — Sales Tax Dispute(1) Dispute(2) — 2,398 54,048 Executive search costs 1,675 — Restructuring/severance 259 5,596 Asset impairment — 3,443 Adjusted operating income $ 855,308 $ 843,432 $ 832,653 1.3% 1.4% Operating margin 28.3 % 32.2 % 31.8 % Adjusted operating margin(2) margin(3) 34.5 % 36.3 % 37.8 % Net income $ 533,481 $ 597,040 $ 537,126 11.2% (10.6)% Intangible asset amortization 58,762 54,074 49,529 Restructuring/severance 35,625 192 CEO onboarding costs(1) 15,053 1,240 Impairment within Other assets(4) 12,338 — Business disposition, acquisitions and related costs 6,365 13,150 India Labor Codes Reform 2,223 — Asset impairment 684 — Client bankruptcy charges 578 — Litigation reserve 501 — Sales Tax Dispute(2) — 1,775 Gain on business divestiture — (17,205) Gain on sale of investments (5,015) — Business divestiture, acquisitions and related costs 13,150 650 Sales Tax Dispute(1) 1,775 39,727 Executive search costs 1,240 Non-operating income from business disposition (604) — Restructuring/severance 192 4,113 Asset impairment — 2,531 Income tax items (493) 1,351 1,397 Adjusted net income(3) income(5) $ 659,498 $ 651,617 $ 635,073 2.6% Net income $ 597,040 $ 537,126 11.2% Interest expense 56,324 65,778 Income taxes 123,918 114,377 Depreciation and amortization expense 157,691 125,187 EBITDA $ 934,973 $ 842,468 11.0% Non-recurring non-cash expenses — 5,070 Adjusted EBITDA $ 934,973 $ 847,538 10.3% Diluted EPS $ 15.55 $ 13.91 11.8% Intangible asset amortization 1.41 1.27 Gain on business divestiture (0.45) — Business divestiture, acquisitions and related costs 0.34 0.02 Sales Tax Dispute(1) 0.05 1.03 Executive search costs 0.03 — Restructuring/severance 0.01 0.11 Asset impairment — 0.07 Income tax items 0.04 0.04 Adjusted Diluted EPS(3) $ 16.98 $ 16.45 3.2% Weighted average common shares (diluted) 38,385 38,618 1.2%
Source: Item 7, 10-K 0001628280-26-066391 vs Item 7, 10-K 0001628280-25-045769
Risk Factors 191 words changed in this paragraph; it is 62% similar to last year's version.
We use, and are expanding our use of, machine learning and AI technologies in our products and processes. If we fail to keep pace with rapidly evolving AI technological developments, or fail to launch products that are competitive, our competitive position and business results may be negatively impacted. If our competitors or other third parties incorporate AI technologies, such as emerging generative and agentic AI, into their products and processes more quickly or more successfully than us, this could impair our ability to compete effectively. Our use of AI technologies, including generative and agentic AI, requires resources to develop, test and maintain such products, which is costly. Despite our investments in, and commitment of resources to, the development of AI products and technologies, we may not be successful in generating revenues from these efforts. In addition, third parties may be able to use AI to create technology that could reduce demand for our products and services. Even where our AI-enabled products and services are adopted, we may be unable to monetize them profitably. The cost of developing, delivering and operating AI capabilities — including model licensing, inference and compute costs and the consumption of AI tokens — can be significant and variable, and has increased as we expand our use of AI. Our historical pricing has been based substantially on subscription and user-based models, and our efforts to introduce consumption-, usage- or outcome-based pricing that better aligns the price of our AI-enabled offerings with their underlying cost and value may not succeed or may not be accepted by clients. If client adoption or usage of our AI features exceeds our expectations, or if we are unable to accurately forecast usage, price our offerings appropriately, or pass through the associated costs, our AI-related costs may exceed the revenues these offerings generate, and increased usage could adversely affect our margins. Conversely, if adoption develops more slowly than anticipated, we may be unable to recover our AI investments within the timeframe we expect, or at all. Any of the foregoing could adversely affect our profitability, margins and results of operations.
Source: Item 1A, 10-K 0001628280-26-066391 vs Item 1A, 10-K 0001628280-25-045769
Accounting Policies 142 words changed in this paragraph; it is 40% similar to last year's version.
In December 2023, September 2025, the FASB issued ASU 2023-09, Income Taxes (Topic 740) Accounting Standards Update ("ASU") 2025-06, Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40) - Targeted Improvements to Income Tax Disclosures. the Accounting for Internal-Use Software. This ASU enhances annual income tax disclosures primarily related removes all references to our effective tax rate reconciliation prescriptive and income taxes paid. sequential software development stages, and requires entities to start capitalizing eligible software costs when management has authorized and committed to funding the software project and it is probable that the project will be completed and the software will be used to perform the function intended. The amendments in this ASU are to can be applied prospectively, although using a prospective, modified, or retrospective application is permitted, transition approach, and are effective for our interim and annual financial statements periods starting in fiscal 2026. 2029. Early adoption is permitted. This ASU is not expected to have a material impact on our Consolidated Financial Statements. permitted at the beginning of an annual period. We are currently assessing the impact of the new requirements on our Consolidated Financial Statements and disclosures.
Source: Item 8, Note 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, 10-K 0001628280-26-066391 vs Item 8, Note 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, 10-K 0001628280-25-045769
Legal Proceedings 127 words changed in this paragraph; it is 61% similar to last year's version.
In the normal course of our business, we are, or may be, are engaged in various legal proceedings, claims, litigation and litigation, and are from time to time subjected to government and regulatory proceedings. proceedings, investigations, and inquiries. In view of the uncertainty inherent in litigation and regulatory such matters, we cannot predict the eventual outcome of such matters or the timing of their resolution, or in most cases reasonably estimate what the eventual judgments, damages, fines, penalties or impact of activity restrictions (if any) restrictions may be. While As a result, we cannot predict the outcome provide assurance that such outcomes will not have a material adverse effect on our consolidated financial position, results of these matters, based operations, cash flows, business or competitive position. Based on information available at August 31, 2025, our 2026, management believes that the ultimate outcome resolution of these unresolved matters against us, that are currently pending or asserted, individually or in the aggregate, will not have a material adverse effect on our consolidated financial position, our results of operations or our cash flows. As litigation or the process to resolve pending matters progresses, we will continue to review the latest information available and assess our ability to predict the outcome of such matters and the effects, if any, on our consolidated financial position, results of operations, cash flows, business or competitive position.
Source: Item 3, via Note 11 – COMMITMENTS AND CONTINGENCIES, 10-K 0001628280-26-066391 vs Item 3, via Note 12 – COMMITMENTS AND CONTINGENCIES, 10-K 0001628280-25-045769